Next Generation Sequencing (NGS) services, also known as high-throughput sequencing, is term used to describe sequencing technologies, such as Illumina sequencing, Roche 454 sequencing, and SOLiD sequencing. These technologies enable to sequence DNA and RNA quickly and cheaply as compared to traditional technologies, such as Sanger sequencing. The studies conducted to determining the origin of life for all species and their evolution have become more challenging. In order to understand the organisms, the use of various next generation sequencing technologies is inevitable. Technological advancements present new pathways for the NGS services industry.
The driving factors of the European NGS services market are faster and cost-efficient sequencing, rising preference of NGS over other platforms, and rising prevalence of inherited diseases. In addition, application of genomics in drug discovery, growing prevalence of cancer & other malignant diseases, and partnerships among companies, R&D centers, and universities supplement growth. However, the factors hindering the growth of the market are reliability on grants and funding from the government and decrease in capital expenditure from academic institutions. Technological advancements opened new opportunities in the market.The European NGS services market is segmented based on technology, application, end user, disease type, and country. The technology segment is classified into SBS, ion semiconductor, SBL, pyro-sequencing, and SMRT. The market is further segmented based on application into research, clinical, and sequencing applications. The sequencing application segment is further classified into RNA, targeted, exome, whole genome, chip, methyl, de novo, and others.
The European NGS services market is further segmented based on disease type into oncology (prostate, lung, & breast cancer) and rare diseases. The end user segment is further classified into research centers, academic & government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and others. The market is divided based on countries into U.K., Germany, France, Italy, Spain, Netherlands, Rest of the Europe (RoE).The key market player profiled in the report are Beijing Genomics Institute (BGI), Cegat (Centre for Genomics and Transcriptomics) GMBH, DNA Vision SA, Eurofins Genomics Inc., Febit / Comprehensive Biomarker Center GMBH (CBC), Genomnia SRL, Mina INC., Macrogen Inc., Microsynth AG, Seqomics, Source Bio Science. They have implemented strategies, such as merger & acquisitions, partnerships, agreements, and others to gain strong foothold in the market.
KEY BENEFITS FOR STAKEHOLDERS:
KEY MARKET SEGMENTS:
By Disease Type
By End User
Key Market Players:
SIMILAR MARKET STUDIES
The current veterinary diagnostics market is largely characterized through the U.S. companion animal diagnostics market and European food animal diagnostics market. Companion animal diagnostics in Europe, rest of world companion diagnostics and food animal infectious disease diagnostics represent submarkets with significant potential for growth, also Chinese market. International trade, public health, ...
June 2015 | $3500 | View Details >>
The United States Protein POC Analyzer Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Protein POC Analyzer industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Protein POC Analyzer market analysis is ...
May 2016 | $3800 | View Details >>
Complete report $11,500. DataPack (test volumes, sales forecasts, supplier shares) $7,500. “2015-2019 Clinical Chemistry and Immunodiagnostics Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations” is a new strategic analysis of major business opportunities emerging in the US clinical chemistry and immunodiagnostic hospital, commercial and point-of-care/POC markets during the next five ...
August 2015 | $7500 | View Details >>
2016 US Automated Microbiology Market: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics-Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
This DataPack contains tables from VPGMarketResearch.com new report, 2016 US Automated Microbiology Market: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review. For pricing information on DataPack sections or individual tables, please contact Customer Service.
January 2016 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research